{"id":"https://openalex.org/W2947564243","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2600","title":"First-in-human (FIH) trial evaluating immune activation and safety of PIN- 2 administered intravenously to patients with advanced solid tumors.","display_name":"First-in-human (FIH) trial evaluating immune activation and safety of PIN- 2 administered intravenously to patients with advanced solid tumors.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947564243","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2600","mag":"2947564243"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.2600","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2600","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.2600","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055114065","display_name":"Colin B. Bier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Bier","raw_affiliation_strings":["PIN Pharma, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PIN Pharma, Inc., New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111060479","display_name":"Michael J. Millward","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Millward","raw_affiliation_strings":["School of Medicine and Pharmacology, Nedlands, WA, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine and Pharmacology, Nedlands, WA, Australia;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052972588","display_name":"Dusan Kotasek","orcid":"https://orcid.org/0000-0002-2170-3560","observed_orcids":["https://orcid.org/0000-0002-2170-3560"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Dusan Kotasek","raw_affiliation_strings":["Adelaide Cancer Centre and University of Adelaide, Kurralta Park, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelaide Cancer Centre and University of Adelaide, Kurralta Park, Australia;","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008704510","display_name":"Kenneth J. Gorelick","orcid":"https://orcid.org/0000-0002-0481-5739","observed_orcids":["https://orcid.org/0000-0002-0481-5739"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth J Gorelick","raw_affiliation_strings":["PIN Pharma, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PIN Pharma, Inc., New York, NY;","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Joshua Brian Goldberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua Brian Goldberg","raw_affiliation_strings":["PIN Pharma, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PIN Pharma, Inc., New York, NY;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"2600","last_page":"2600"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.8550000190734863},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6200000047683716},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.7630000114440918},{"id":"https://openalex.org/keywords/th1-cytokines","display_name":"Th1 cytokines","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6949999928474426},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.7649999856948853},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5460000038146973},{"id":"https://openalex.org/keywords/immune-activation","display_name":"immune activation","score":0.5049999952316284},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.4740000069141388},{"id":"https://openalex.org/keywords/monocyte-differentiation","display_name":"monocyte differentiation","score":0.47999998927116394},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.597000002861023},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.5569999814033508},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.609000027179718},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8237851858139038},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5251935720443726},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.4587356150150299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43833857774734497},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3860968351364136},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3229089081287384}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.2600","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2600","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.2600","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2403964363","https://openalex.org/W2562249209","https://openalex.org/W4406387031","https://openalex.org/W2112100378","https://openalex.org/W4410802894","https://openalex.org/W4308384996","https://openalex.org/W2797682278","https://openalex.org/W2335103830","https://openalex.org/W4404052892","https://openalex.org/W3166087827"],"abstract_inverted_index":{"2600":[0],"Background:":[1],"Innate":[2],"immunity":[3,13,34],"is":[4,20,355],"an":[5,321,327],"integral":[6],"component":[7],"necessary":[8],"to":[9,67,85,171,183],"initiate":[10],"systemic":[11],"anti-tumor":[12],"in":[14,35,55,77,113,191,213,308,310,330,344,349],"patients":[15,78],"with":[16,80,224,320,333,346,351],"progressive":[17],"malignancy.":[18],"PIN-2":[19,135,197,218,315,325],"a":[21,27,60,104,144,286],"novel":[22],"immunomodulating":[23],"agent":[24],"derivatized":[25],"from":[26,222],"transactivator":[28],"(Tat)":[29],"protein":[30],"that":[31],"stimulates":[32],"innate":[33,49],"vivo":[36],"by":[37,143,337],"promoting":[38],"differentiation":[39],"of":[40,62,92,106,122,134,152,205,262],"peripheral":[41],"blood":[42],"monocytes":[43],"into":[44],"activated":[45],"APC\u2019s":[46],"linking":[47],"the":[48,68,87,214,311],"and":[50,90,103,124,159,167,240,265,279,281,293,343],"adaptive":[51],"immune":[52,173,206],"systems":[53],"resulting":[54],"endogenous":[56],"T-cell":[57],"priming":[58],"against":[59],"multitude":[61],"tumor":[63],"associated":[64],"antigens":[65],"unique":[66],"individual.":[69],"Methods:":[70],"A":[71,149,188],"FIH":[72],"clinical":[73],"trial":[74,358],"was":[75,154,163,193,219,285,316],"conducted":[76],"(pts)":[79],"extensively":[81],"pretreated":[82],"solid":[83,353],"tumors":[84,354],"evaluate":[86,172],"pharmacodynamics":[88],"(PD)":[89],"safety":[91,323],"PIN-2.":[93],"8":[94],"pts":[95,118,247,299,350],"(2":[96],"men),":[97],"mean":[98,225],"age":[99],"62.7":[100],"(\u00b17.9)":[101],"years,":[102],"median":[105],"4.5":[107],"prior":[108],"treatment":[109,123,153],"lines,":[110],"were":[111,130,181,209,276],"enrolled":[112],"2":[114,117,127,140,250,256,298],"Australian":[115],"centers.":[116],"received":[119,126],"1":[120,145,170,259,266,278],"cycle":[121,151],"6":[125,166],"cycles.":[128],"Pts":[129],"given":[131],"300":[132],"\u00b5g":[133],"IV":[136],"3":[137,246,290],"times/wk":[138],"for":[139,251,267],"wks":[141],"followed":[142],"wk":[146],"rest":[147],"period.":[148],"2nd":[150],"offered":[155],"based":[156],"on":[157,270],"pt":[158],"investigator":[160],"preference.":[161],"Plasma":[162],"collected":[164],"at":[165],"24H":[168],"post-infusion":[169],"activation.":[174,207],"Th1":[175],"cytokines":[176],"(TNF-\u03b1,":[177],"IFN-\u03b3,":[178],"IL-12,":[179],"CSF-2)":[180],"analyzed":[182],"assess":[184],"PD":[185,334],"activity.":[186],"Results:":[187],"significant":[189],"increase":[190,329],"TNF-\u03b1":[192],"seen":[194],"6H":[195],"following":[196],"infusion":[198,257],"(p":[199],"=":[200,227,232,242],"0.0142),":[201],"demonstrating":[202],"rapid":[203],"onset":[204],"There":[208,284],"no":[210,294],"clear":[211],"changes":[212,309],"other":[215,347],"parameters":[216],"evaluated.":[217],"rapidly":[220],"cleared":[221],"plasma,":[223],"T1/2":[226],"24.0":[228],"(8.07)":[229],"min,":[230,235],"Tmax":[231],"1.06":[233],"(0.665)":[234],"Cmax=":[236],"77,500":[237],"(61,600)":[238],"pg/mL,":[239],"AUC0-inf":[241],"690,000":[243],"(493,000)":[244],"pg\u2022min/mL.":[245],"discontinued":[248],"treatment,":[249],"adverse":[252],"events":[253],"(1":[254],"gr":[255,289],"reaction,":[258],"unrelated":[260,288],"SAE":[261],"abdominal":[263],"pain)":[264],"disease":[268],"progression":[269],"day":[271],"12.":[272],"Treatment":[273],"related":[274],"AEs":[275,295],"grade":[277],"2,":[280],"readily":[282],"managed.":[283],"single":[287],"event":[291],"(anemia)":[292],">":[296],"gr3.":[297],"developed":[300],"anti-drug":[301],"antibodies;":[302],"however,":[303],"these":[304],"did":[305],"not":[306],"result":[307],"immuno-PD":[312],"profile.":[313,324],"Conclusions:":[314],"generally":[317],"well":[318],"tolerated":[319],"acceptable":[322],"caused":[326],"early":[328],"TNF-\u03b1,":[331],"consistent":[332],"activity":[335],"predicted":[336],"preclinical":[338],"data.":[339],"Further":[340],"study":[341],"alone":[342],"combination":[345],"agents":[348],"advanced":[352],"warranted.":[356],"Clinical":[357],"information:":[359],"ACTRN12617001597381.":[360]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2019-06-07T00:00:00"}